Mahdieh Abbasalizad Farhangi, Leila Nikniaz, Zeinab Nikniaz
ScienceDirect • Dec 2, 2025
Angélica Villarruel‐López, David A. López-de la Mora, Olga Vázquez-Paulino, Ana Graciela Puebla‐Mora, Ma. Refugio Torres-Vitela, L. A. Guerrero-Quiroz, Karla Nuño
Angélica Villarruel‐López, David A. López-de la Mora, Olga Vázquez-Paulino et al. (2018). Effect of Moringa oleifera consumption on diabetic rats. BMC Complementary and Alternative Medicine. doi:10.1186/s12906-018-2180-2
Researchers tested whether consuming moringa leaf powder could safely reduce blood sugar in diabetic rats while examining effects on weight, cholesterol, and gut bacteria. Unlike most previous studies that used concentrated leaf extracts, this investigation used powdered leaves to better reflect how people typically consume moringa in their diets. The team first confirmed the powder was safe by testing for toxicity and DNA damage, then induced diabetes in laboratory rats using alloxan (a chemical that destroys insulin-producing cells) and fed them different amounts of moringa powder. The results showed moringa consumption successfully lowered blood glucose levels below 250 mg/dL in diabetic rats, demonstrating a clear hypoglycemic effect. However, the treatment also caused unexpected weight gain of more than 30 grams compared to untreated diabetic rats. The researchers found no changes in overall numbers of beneficial lactic acid bacteria in the gut, but did observe shifts in the specific types of bacteria present. This study provides important safety data for moringa leaf powder consumption and confirms its blood sugar-lowering properties, though the weight gain effect warrants further investigation to understand the underlying mechanisms.
Population
Alloxan-induced diabetic Sprague Dawley rats (specific sample size not reported in abstract)
Plant part
Leaf
Preparation
Powder
dosage not specified in abstract
Mahdieh Abbasalizad Farhangi, Leila Nikniaz, Zeinab Nikniaz
ScienceDirect • Dec 2, 2025
Morvaridzadeh M., Fazelian S., Agah S. et al.
Nutrients (MDPI) • Nov 7, 2025
Sarah J. Johnson, Michael R. Thompson, Lisa K. Anderson et al.
Heliyon • Mar 22, 2025